From a pharmacodynamic point of view, oncolytic viruses result in increased production of interferon, CD8+ T-cells and the expression of programmed death ligand 1 (PD-L1) in the tumor microenvironment, as well as reduced populations of suppressor T-cells. Here, CD274 is linked to neoplasm.